Research Cart
Your cart is empty
Add research compounds to get started.
Tesamorelin
Stabilized GHRH Analog
Tesamorelin is a synthetic stabilized analog of human growth hormone-releasing hormone (GHRH) consisting of the full 44-amino acid sequence of GHRH with a trans-3-hexenoic acid group added to the N-terminus. This modification significantly increases its stability and resistance to degradation compared to native GHRH. Tesamorelin acts on the pituitary gland to stimulate the synthesis and pulsatile release of endogenous growth hormone. It has been studied extensively in clinical trials for its effects on visceral adipose tissue, IGF-1 levels, and lipid metabolism, making it a valuable tool in metabolic and endocrine research.
Technical Specifications
Research Use Only. This compound is sold for laboratory and research purposes only. Not for human consumption, veterinary use, or therapeutic application.
Research Applications
Research Studies
Peer-reviewed literature for Tesamorelin
Tesamorelin Reduces Visceral Adiposity and Improves Metabolic Parameters in HIV-Infected Patients
Effects of Tesamorelin on Visceral Fat and Liver Fat in HIV-Infected Patients with Abdominal Lipohypertrophy
Growth Hormone-Releasing Hormone Analogs: Clinical and Research Applications
Tesamorelin and IGF-1 Axis Modulation: Mechanistic Insights
Related Compounds
SermorelinA synthetic analog of the first 29 amino acids of growth hormone-releasing hormone (GHRH). Studied for GH secretion research.
CJC-1295A tetrasubstituted 30-amino acid peptide hormone with a long half-life. Studied for sustained GH secretion research.
IpamorelinA selective growth hormone secretagogue and ghrelin mimetic. Studied for its highly selective GH-releasing properties.